(Q38238547)

English

Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

V R Patwardhan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

N Sengupta

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

A Bonder

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

D Lau

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

0 references

publication date

11 August 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

40

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

804-810

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

'e' antigen defective hepatitis B virus and course of chronic infection

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Longitudinal change of liver stiffness by transient elestography in chronic hepatitis B patients treated with nucleos(t)ide analogue

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Assessment of liver fibrosis with elastography point quantification technique in chronic hepatitis B virus patients: a comparison with liver pathological results.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Cost-effectiveness of viral hepatitis B & C treatment

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Relapse of chronic hepatitis B after discontinuation of nucleos(t)ide analogs: is the glass half full or half empty?

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALT

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

1 reference

https://api.crossref.org/works/10.1111%2FAPT.12908

21 January 2018

Identifiers

10.1111/APT.12908

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25109610%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38238547&oldid=1590380590"